Anti-platelet membrane glycoprotein vi monoclonal antibody
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- MOCHIDA PHARM CO LTD
- Publication Date
- 2009-02-12
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
TECHNICAL FIELD
[0001] The present invention relates to an antibody to human platelet membrane glycoprotein VI (hereinafter, sometimes abbreviated as GPVI) and a recognition region of the antibody.BACKGROUND ART
[0002] The platelet plays a very important role in the clot formation and the biophylaxis, and its concerning in various clinical condition is being elucidated from the physiological role. In particular, it is remarkable about the function that the platelet forms a hemostatic plug. For example, when the vascular endothelial cell suffers damage, the collagen that is the major matrix protein of the subcutaneous vascular endothelium is exposed and the platelet adheres thereto. Next, the platelet is activated by the signal from the collagen and when finally, the platelet agglutinates through the fibrinogen. Then, since this fact causes morbidity such as thromboembolic disease depending on the situation, it is remarkable as a target for therapy.
[0003] In the past, for the purpose of t...